Kratochwil, C. Et Al. 2023. Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). European Journal of Nuclear Medicine and Molecular Imaging , vol.50, no.9 , 2830-2845.

Kratochwil, C., Fendler, W. P., Eiber, M., Hofman, M. S., Emmett, L., Calais, J., ... Osborne, J. R.(2023). Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). European Journal of Nuclear Medicine and Molecular Imaging , vol.50, no.9, 2830-2845.

Kratochwil, Clemens Et Al. "Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)," European Journal of Nuclear Medicine and Molecular Imaging , vol.50, no.9, 2830-2845, 2023

Kratochwil, Clemens Et Al. "Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)." European Journal of Nuclear Medicine and Molecular Imaging , vol.50, no.9, pp.2830-2845, 2023

Kratochwil, C. Et Al. (2023) . "Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)." European Journal of Nuclear Medicine and Molecular Imaging , vol.50, no.9, pp.2830-2845.

@article{article, author={Clemens Kratochwil Et Al. }, title={Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)}, journal={European Journal of Nuclear Medicine and Molecular Imaging}, year=2023, pages={2830-2845} }